KalVista Pharmaceuticals (KALV) EPS (Basic) (2014 - 2025)
KalVista Pharmaceuticals (KALV) reported EPS (Basic) of -$1.12 for Q3 2025, down 28.51% on a YoY basis from -$1.57 in Q3 2024, and down 6.86% sequentially from -$1.05 in Q2 2025.
KalVista Pharmaceuticals (KALV) EPS (Basic) (2014 - 2025) Analysis & Trends
KalVista Pharmaceuticals (KALV) has 12 years of EPS (Basic) data on file, last reported at -$1.12 in Q3 2025.
- For the quarter ending Q3 2025, EPS (Basic) fell 28.51% year-over-year to -$1.12; the trailing twelve-month figure through Jul 2025 stood at -$3.07 (down 79.62% YoY), and the FY2025 full-year result was -$3.69, down 158.09% from the prior year.
- EPS (Basic) slipped to -$1.12 in Q3 2025, from -$1.05 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.8 in Q2 2024 to a low of -$2.34 in Q2 2022.
- A 5-year average of -$1.1 and a median of -$1.12 in 2025 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) surged 173.39% in 2024 and slumped 231.92% in 2025, its largest moves.
- Tracing KALV's EPS (Basic) over 5 years: stood at -$1.36 in 2021, then fell by 10.92% to -$1.51 in 2022, then climbed by 25.5% to -$1.13 in 2023, then advanced by 1.13% to -$1.11 in 2024, then declined by 0.83% to -$1.12 in 2025.
- Business Quant data shows KALV's EPS (Basic) at -$1.12 in Q3 2025, -$1.05 in Q2 2025, and -$1.11 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -1.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -1.12 |
| Apr 30, 2025 | -1.05 |
| Oct 31, 2024 | -1.11 |
| Jul 31, 2024 | -0.87 |
| Apr 30, 2024 | 0.80 |
| Jan 31, 2024 | -0.84 |
| Oct 31, 2023 | -1.13 |
| Jul 31, 2023 | -1.13 |
| Apr 30, 2023 | -1.09 |
| Jan 31, 2023 | -1.32 |
| Oct 31, 2022 | -1.51 |
| Jul 31, 2022 | -1.55 |
| Apr 30, 2022 | -2.34 |
| Jan 31, 2022 | -1.55 |
| Oct 31, 2021 | -1.36 |
| Jul 31, 2021 | -0.90 |
| Apr 30, 2021 | -1.01 |
| Jan 31, 2021 | -0.73 |
| Oct 31, 2020 | -0.74 |
| Jul 31, 2020 | -0.83 |